Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Oncogene|December 6, 2022
Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to LenvatinibYufeng Liu, Linmao Sun, Hongrui Guo, et al.
Cancer Research|September 28, 2021
A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma ProgressionShuhang Liang, Hongrui Guo, Kun Ma, et al.
Molecular Cancer|May 17, 2018
Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferationXirui Liu, Yingjian Liang, Ruipeng Song, et al.
Life Sciences|October 15, 2020
Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC)Guangchao Yang, Yuanfei Yao, Dehai Wu, et al.
Frontiers in Molecular Neuroscience|December 29, 2022
Inflammation-activated C/EBPβ mediates high-fat diet-induced depression-like behaviors in miceYiyi Li, Hongyu Chen, Jianhao Wang, et al.
Nature Communications|June 18, 2024
Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitorsLinmao Sun, Yufeng Liu, Xinyu Guo, et al.
Cell Death & Disease|February 16, 2018
STK17B promotes carcinogenesis and metastasis via AKT/GSK-3β/Snail signaling in hepatocellular carcinomaYaliang Lan, Jihua Han, Yan Wang, et al.
The EMBO Journal|January 28, 2025
Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axisYan Huang, Hua Lu, Yao Liu, et al.
Brain, Behavior, and Immunity|March 31, 2024
A TrkB cleavage fragment in hippocampus promotes Depressive-Like behavior in miceJianhao Wang, Hang Yu, Xiang Li, et al.
Pageof 11